Maria C. Mico

89133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Journal: Bone marrow transplantation

Published: March 02, 2026

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Journal: Cancers

Published: December 02, 2025

Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.

Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: October 25, 2025

Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia.

Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia.

Journal: Mediterranean journal of hematology and infectious diseases

Published: September 04, 2025

CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.

CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.

Journal: Mediterranean journal of hematology and infectious diseases

Published: August 09, 2025

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

Journal: Cancers

Published: August 06, 2025

Treosulfan-based double-alkylator conditioning in myelofibrosis: An Italian retrospective multicenter analysis.

Treosulfan-based double-alkylator conditioning in myelofibrosis: An Italian retrospective multicenter analysis.

Journal: Bone marrow transplantation

Published: August 04, 2025

Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy.

Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy.

Journal: Bone marrow transplantation

Published: February 19, 2025

Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study.

Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study.

Journal: Transplantation and cellular therapy

Published: February 01, 2025

The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis.

The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis.

Journal: Open forum infectious diseases

Published: November 24, 2024

Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.

Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.

Journal: Bone marrow transplantation

Published: October 18, 2024

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

Journal: Cancers

Published: August 20, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026